HNST heads into its Q1 2026 earnings report today with short sellers retreating — quietly signalling more caution about pressing the bear trade than the headline numbers might suggest.
Short interest has fallen sharply from its recent peak. It topped 12% of the free float in early April during the tariff-driven market selloff, then declined steadily to around 10.2% now — a drop of roughly two percentage points in five weeks. The borrow market reinforces that picture: cost to borrow is a negligible 0.59%, and availability remains wide, with utilization running near 25% against a 52-week peak of 53%. That means the lending pool is well-supplied and there is no meaningful squeeze pressure heading into the event. The stock itself has recovered sharply — up 20% over the past month to $3.39, suggesting some shorts have been covering into strength.
Options traders are not adding much drama. The put/call ratio of 0.11 is barely above its 20-day average of 0.105, producing a z-score close to zero. At the low end of its 52-week range (52-week high: 0.39), options positioning reflects a heavily call-skewed book — investors have been buying upside rather than hedging downside. That is consistent with the price recovery but does add a note of caution about how much goodwill is already priced in.
The analyst debate is thin and dated. The most recent changes in the data come from late February 2026 — well outside the 14-day window for meaningful currency — with Telsey Advisory maintaining a Market Perform at $3.00. JP Morgan's downgrade to Underweight from Overweight, recorded in January, is the most meaningful recent directional signal from a bellwether firm, though that came when the stock was trading lower. The bull case centres on Honest's expansion into larger-kids and adult care categories, its digital platform, and ongoing cost cuts. Bears point to persistent weakness in diapers and apparel, negative margins, and the risk that its category-exit strategy doesn't offset volume headwinds fast enough. The valuation context is complex: the trailing PE of 28.5x has expanded by 4.8 points over the past month on the back of the price rally, making the stock less obviously cheap heading into the release.
Insider activity from March adds a subtle overhang. CEO Carla Vernon and several senior executives sold shares on March 5 at $2.85 — a cluster of routine sales, but worth noting that those sellers have already crystallised gains relative to where the stock trades today. Vernon remains a top-five holder with a 3.8% stake, so alignment is intact, but the timing reinforces that near-term upside was not universally expected inside the company at the time.
The print will test whether the category-mix shift and gross margin progression can justify both the 20% one-month re-rating and the remaining short interest of roughly 10% of float — a level that could compress further or rebuild sharply depending on what management says about the path to sustained profitability.
See the live data behind this article on ORTEX.
Open HNST on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
